Multicenter study of levodopa carbidopa intestinal gel in Parkinson's disease: the Turkish experience


Creative Commons License

GÜLTEKİN M., ULUKAN Ç., Tezcan S., DOĞU O., Hanagasi H., Bilgic B., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.50, sa.1, ss.66-85, 2020 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.3906/sag-1904-150
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.66-85
  • Anahtar Kelimeler: Parkinson's disease, levodopa carbidopa intestinal gel, efficacy, LONG-TERM, OPEN-LABEL, MOTOR COMPLICATIONS, NONMOTOR SYMPTOMS, DOUBLE-BLIND, INFUSION, 12-MONTH, THERAPY, SAFETY
  • Gazi Üniversitesi Adresli: Evet

Özet

Background/aim: Our purpose was to determine the efficacy of levodopa carbidopa intestinal gel (LCIG) in a series of Turkish patients with Parkinson's disease (PD).